BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,302,000 | -13.2% | 10,985 | +0.9% | 0.04% | -22.2% |
| Q4 2021 | $1,500,000 | -76.7% | 10,885 | -85.5% | 0.05% | -76.9% |
| Q4 2020 | $6,428,000 | -63.9% | 75,000 | -77.1% | 0.23% | -85.1% |
| Q4 2019 | $17,802,000 | +25.5% | 327,000 | -3.8% | 1.57% | -35.4% |
| Q3 2019 | $14,185,000 | +8.0% | 340,000 | +13.3% | 2.42% | +21.5% |
| Q2 2019 | $13,137,000 | +750.8% | 300,000 | +900.0% | 2.00% | +806.8% |
| Q1 2019 | $1,544,000 | +14.9% | 30,000 | -42.5% | 0.22% | -72.3% |
| Q1 2018 | $1,344,000 | +18.1% | 52,186 | +23.7% | 0.79% | +66.8% |
| Q4 2017 | $1,138,000 | – | 42,186 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |